Journal of Leukemia

Journal of Leukemia
Open Access

ISSN: 2329-6917

+44-7482-875032

David Naor

David Naor

David Naor
Professor, The Lautenberg Center of General and Tumor Immunology
The Hebrew University Hadassah Medical School, Israel

Biography

Professor David Naor is a professor of immunology in the Hebrew University-Hadassah Medical School and was the head of Milton Winograd chair of cancer studies. Professor Naor served as associate visiting professor, Department of Microbiology and Immunology, UCLA, 1975-1976, visiting professor, University of South Florida, Tampa, Florida, March 1979, June 1980, visiting professor, Harvard Medical School, Summer 1984, visiting scientist, Memorial Sloan-Kettering Cancer Institute, New York, Summer 1985, visiting professor, Charing Cross Sunley Research Centre, London, September 1987 to November 1988. Professor Naor was invited as plenary lecturer in many scientific conferences such as New York Academy of Science Conferences, International Congresses on Autoimmunity in Tel Aviv, Budapest , Sorrento ,Porto, Lubljana and Granada and the hyaluronan 2003 symposium in Cleveland as well as an invited speaker in a conference entitled “from the laboratory to the clinic, September 1988, September 1991, September 1993, September 1994, September 1996, October 1998, September 1999, September 2000,September 2001 September 2002,September 2003, September,2005, September, 2007, September 2008,september 2010; September 2012, September 2013 .Professor Naor received grants from NIH USA, Leukemia Foundation USA, United States-Israel Binational Science Foundation, German Cancer Foundation, German-Israel Foundation and the Israel Ministry of Commerce and Industry, as well as from other agencies. Professor Naor published a book entitled Immunosuppression and Human Malignancy", Humana Press, New Jersey, 1988 as well as 149 articles in the international literature. Professor Naor is supervising at present 4 post docs Prof Naor is a founder of the start-up company Maimonidex. Professor Naor was a member of the editorial board of Journal of Autoimmunity. Professor Naor received award from Johnson & Johnson, Focused Giving Program "In recognition of outstanding research toward the advances of science and technology in health care." Prof Naor received the 2013 prize of the Faculty of Medicine , Hebrew University of Jerusalem for its “continuing distinguished achivements in research and teaching”.

Research Interest

Involvement of CD44 and RHAMM (CD168) in chronic inflammatory and malignant diseases. Autoimmune diseases , including type 1 and 2 diabetes, multiple sclerosis and rheumatoid arthritis. Adhesion and homing molecules. Translation medicine

Top